Neoadjuvant metformin added to Systemic Therapy increases Pathological Complete Response in Breast cancer: A cross-sectional study, Hospital Mexico, Costa Rica. A Van Der Laat, D Landaverde; A. Ramos. Archives of Breast Cancer 2018; Vol 5, No1:32-37.
Allan Ramos-Esquivel, Alicia van der Laat, Raquel Rojas-Vigott, Melissa Juárez, Luis Corrales-Rodríguez. Anti-PD-1/anti-PD-L1 immunotherapy versus docetaxel for previously treated advanced non-small cell lung cancer: a systematic review and meta-analysis of randomised clinical trials. ESMO Open 2017;2: e000236. doi:10.1136/esmoopen-2017-000236.
Abstracts:
Neoadjuvant metformin along with systemic therapy increase pathological complete responses in breast cancer: Results of a cross-sectional study, Hospital Mexico, Costa Rica. A Van Der Laat, D Landaverde; J Clin Oncol 34, 2016 (suppl; abstr e12519).
First line treatment with Erlotinib in advanced non squamous NSCLC: our experience. CCSS, San José, Costa Rica. R Rojas, A van der Laat, A Ramos, 7th Latin American Conference on lung Cancer, IASLC, Panamá, 2016.